Evaluation of fluconazole resistance mechanisms in Candida albicans clinical isolates from HIV-infected patients in Brazil

Diagnostic Microbiology and Infectious Disease

Volumn 50, Issue 1, 2004, Pages 25-32

  Goldman, Gustavo H ^a   Da Silva Ferreira, Márcia Eliana ^a   Dos Reis Marques, Everaldo ^a   Savoldi, Marcela ^a   Perlin, David ^b   Park, Steven ^b   Godoy Martinez, Patricio Christian ^c   Goldman, Maria Helena S ^a   Colombo, Arnaldo L ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; FUNGAL GENE; FUNGAL STRAIN; FUNGUS ISOLATION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; HOMOZYGOSITY; HOSPITAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MATING TYPE; MEASUREMENT; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATIENT; POINT MUTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH AMERICA;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIFUNGAL AGENTS; BASE SEQUENCE; BRAZIL; CANDIDA ALBICANS; CANDIDIASIS; COHORT STUDIES; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; FEMALE; FLUCONAZOLE; GENES, MDR; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHARMACOGENETICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 5444239537     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2004.04.009     Document Type: Article

References (34)

1. Albertson G.D., Niimi M., Cannon R.D., Jenkinson H.F. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance. Antimicrob Agents Chemother. 40:1996;2835-2841
2. Altschul S.F., Madden T.L., Schaffer A.A., Zhang J., Zhang Z., Miller W. Lipman DJ Gapped blast and Psi-Blast A new generation of protein database search programs. Nucl Acids Res. 25:1997;3389-3402
3. Calabrese D., Bille J., Sanglard D. A novel multidrug efflux transporter gene of the major facilitator superfamily from Candida albicans (FLU1) conferring resistance to fluconazole. Microbiology. 146:2000;2743-2754
4. De Backer M.D., Magee P.T., Pla J. Recent developments in molecular genetics of Candida albicans. Ann Rev Microbiol. 54:2000;463-498
5. Franz R., Kelly S.L., Lamb D.C., Kelly E., Ruhnke M., Morschhauser J. Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemothe. 42:1998;3065-3072
6. Georgopapadakou N.H. Antifungals Mechanism of action and resistance, established and novel drugs. Curr Opin Microbiol. 1:1998;547-557
7. Hull C.M., Johnson A.D. Identification of a mating type-like locus in the asexual pathogenic yeast Candida albicans. Science. 285:1999;1271-1275
8. Kolaczkowski M., Kolaczowska A., Luczynski J., Witek S., Goffeau A. In vivo characterization of the drug resistance profile of the major ABC transporters and other components of the yeast pleiotropic drug resistance network. Microbe Drug Resistance. 4:1998;143-158
9. Lai M.H., Kirsch D.R. Nucleotide sequence of cytochrome P450L1A1 (lanosterol 14 alpha-demethylase) from Candida albicans. Nucl Acids Res. 17:1989;804
10. Latgé J.P. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 12:1999;310-350
11. Lamb D.C., Kelly D.E., Schunck W.H., Shyadehi A.Z., Akhtar M., Lowe D.J., Baldwin B.C., Kelly S.L. The mutation T315A in Candida albicans sterol 14alpha-dmethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity. J Biol Chem. 272:1997;5682-5688
12. Loeffler J., Stevens D.A. Antifungal drug resistance. Clin Infect Dis. (36):2003;S31-41
13. Lopez-Ribot J.L., McAtee R.K., Perea S., Kirkpatrick W.R., Rinaldi M.G., Patterson T.F. Multiple resistant phenotypes of Candida albicans coexist during episodes of oropharyngeal candidiasis in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 43:1999;1621-1630
14. Manganelli R., Dubnau E., Tyagi S., Kramer F.R., Smith I. Differential expression of 10 sigma factor genes in Mycobacterium tuberculosis. Mol Microbiol. 31:1999;715-724
15. Marichal P., Koymans L., Willemsens S., Bellens D., Verhasselt P., Luyten W., Borgers M., Ramaekers F.C.S., Odds F.C., Vanden Bossche H. Contribution of mutations in the cytochrome P450 14 alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology. 10:1999;2701-2713
16. Morschhauser J. The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta. 1587:2002;240-248
17. Nascimento A.M., Goldman G.H., Park S., Marras S.A.E., Delmas G., Oza U., Lolans K., Dudley M.N., Mann P.A., Perlin D.S. Multiple resistance mechanisms among Aspergillus fumigatus mutants with high- level resistance to itraconazole. Antimicrob Agents Chemother. 47:2003;1719-1726
18. National Committee for Clinical Laboratory Standards (2002). Reference method for both dilution antifungal susceptibility testing of yeasts. Approved standard. NCCLS document M27A. National Committee for Clinical laboratory Standards, Wayne, Pa
19. Perea S., Patterson T.F. Antifungal resistance in pathogenic fungi. Antimicrob Resist. 35:2002;1073-1080
20. Perea S., López-Ribot J.L., Kirkpatrick W.R., McAtee R.K., Santillán R.A., Martinez M., Calabrese D., Sanglard D., Patterson T.F. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother. 45:2001;2676-2684
21. Podust L.M., Poulos T.L., Waterman M.R. Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc Natl Acad Sci USA. 98:2001;3068-3073
22. Pujol C., Mecer S.A., Pfaller M., Soll D.R. Drug resistance is not directly affected by mating type locus zygosity in Candida albicans. Antimicrob Agents Chemother. 47:2003;1207-1212
23. Rustad T.R., Stevens D.A., Pfaller M.A., White T.C. Homozygosity at the Candida albicans MTL locus associated with azole resistance. Microbiology. 148:2002;1061-1072
24. Sanglard D., Kuchler K., Ischer F., Pagani J.L., Monod M., Bille J. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob Agents Chemother. 39:1995;2378-2386
25. Sanglard D., Ischer F., Monod M., Bille J. Cloning of Candida albicans genes conferring resitance to azole antifungal agents Characterization of CDR2, a new multidrug ABC transporter gene. Microbiology. 143:1997;405-416
26. Sanglard D., Odds F.C. Resistance of Candida species to antifungal agents Molecular mechanisms and clinical consequences. Lancet Infect Dis. 2:2002;73-85
27. Scherer S., Stevens D.A. Application of DNA fingerprinting methods to epidemiology and taxonomy of Candida species. J Clin Microbiol. 25:1987;675-679
28. Semighini C.P., Marins M., Goldman M.H.S., Goldman G.H. Quantitative analysis of the relative transcript levels of ABC transporter Atr genes in Aspergillus nidulans by Real-Time Reverse Transcription-PCR assay. Appl Environ Microbiol. 68:2002;1351-1357
29. Warren N.G., Hazen K.C. Candida, Cryptococcus, and other yeasts of medical importance. Murray P.R. Manual of Clinical Microbiology. 1995;723-737 ASM Press, Washington, DC
30. Wenzel R.P. Nosocomial candidemia Risk factors and attributable mortality. Clin Infect Dis. 20:1995;1531-1534
31. Wilhem J., Pingoud A. Real-time polymerase chain reaction. ChemBioChem. 4:2003;1120-1128
32. White T.C. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother. 41:1997;1482-1487
33. White T.C., Marr K.A., Bowden R.A. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev. 11:1998;382-402
34. White T.C., Holleman S., Dy F., Mirels L.F., Stevens D.A. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother. 46:2002;1704-1713